Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Shutterstock
Best Momentum Stocks to Buy for August 8th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 8th:
Clean Harbors, Inc. (CLH - Free Report) : This provider of environmental and industrial services has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 39.2% over the last 60 days.
Clean Harbors, Inc. Price and Consensus
Clean Harbors, Inc. price-consensus-chart | Clean Harbors, Inc. Quote
Clean Harbors’ shares gained 22.4% over the last three months compared with the S&P 500’s advance of 3.9%. The company possesses a Momentum Score of A.
Clean Harbors, Inc. Price
Clean Harbors, Inc. price | Clean Harbors, Inc. Quote
Eneti Inc. : This company that engages in the offshore wind and marine-based renewable energy businesses has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 263.6% over the last 60 days.
Eneti Inc. Price and Consensus
Eneti Inc. price-consensus-chart | Eneti Inc. Quote
Eneti’s shares gained 19% over the last three months compared with the S&P 500’s advance of 3.9%. The company possesses a Momentum Score of B.
Eneti Inc. Price
Eneti Inc. price | Eneti Inc. Quote
Supernus Pharmaceuticals, Inc. (SUPN - Free Report) : This biopharmaceutical company focused on CNS diseases has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.
Supernus Pharmaceuticals, Inc. Price and Consensus
Supernus Pharmaceuticals, Inc. price-consensus-chart | Supernus Pharmaceuticals, Inc. Quote
Supernus’ shares gained 22% over the last three months compared with the S&P 500’s advance of 3.9%. The company possesses a Momentum Score of B.
Supernus Pharmaceuticals, Inc. Price
Supernus Pharmaceuticals, Inc. price | Supernus Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.